Recent Finacing
Recent Raise
Neumirna Therapeutics is an RNA-focused biotechnology company developing antisense oligonucleotide therapies and an RNA-based drug discovery platform, advancing NMT.001 for drug-resistant epilepsy and Parkinson’s programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
